文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

英格兰全境孕妇及产后女性对呼吸道合胞病毒产前与婴儿免疫接种态度的调查

An England-wide survey on attitudes towards antenatal and infant immunisation against respiratory syncytial virus amongst pregnant and post-partum women.
PubMed 文献 · Vaccine · 2025-07-12

研究通过家长支持组织向73,734名英格兰孕妇或产后6个月内女性发放健康安全局调查问卷,共1061人完成。受访者对母亲RSV疫苗接种的接受度为89.5%(95%CI 87.5-91.3),对婴儿免疫接种的接受度为81.4%(95%CI 79.0-83.7)。多变量分析显示有伴侣者接受度更高,可能与种族有关,贫困和残疾状态无差异。参与者最信任助产士提供的信息。

要点

  • 孕妇对母亲RSV疫苗接受度89.5%,对婴儿免疫接种接受度81.4%。
  • 有伴侣与更高接受度相关,可能与种族有关,贫困和残疾状态无差异。
  • 参与者最信任助产士作为信息来源。

核心结论

  • 母亲和婴儿RSV免疫接种均具有高度可接受性,支持推出任一方案。
  • 持续监测将支持评估项目实施和公平可及性。

研究设计与样本

  • 通过家长支持组织向73,734名女性发送健康安全局调查问卷。
  • 纳入标准为居住于英格兰、18岁及以上、怀孕或孩子不超过6个月。
  • 调查收集基线人口学特征、接受母亲疫苗或婴儿免疫接种的可能性和潜在障碍感知,采用李克特量表和自由文本问题。

主要发现

  • 1061名女性完成调查。
  • 受访者可能接受母亲RSV疫苗接种的比例为89.5%(95%CI 87.5-91.3),可能接受婴儿免疫接种的比例为81.4%(95%CI 79.0-83.7)。
  • 多变量分析显示,有伴侣与更高接受度相关,可能与种族有关。
  • 多变量分析未观察到贫困或残疾状态的差异。
  • 参与者最信任助产士提供信息。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Respiratory syncytial virus (RSV) causes significant morbidity. New immunisations to protect infants have been licensed in the UK including a vaccine in pregnancy and a monoclonal antibody injection in infants. The UK Joint Committee on Vaccination and Immunisation has advised that either could be considered suitable for a national programme. We conducted a survey of pregnant women to understand acceptability and barriers to RSV immunisation. METHODS: 73,734 women were emailed a Health Security Agency survey on decision making around maternal and baby health via a parent support organisation. The survey collected baseline demographics, expressed likelihood of accepting maternal vaccine or immunisation for their infant, and perceptions of potential barriers, using likert scales and free text questions. Eligibility criteria were: pregnant or with a child up to 6 months of age, living in England, 18 years or older. Responses were quantified descriptively; binary logistic regression was used to measure multivariable associations; thematic analysis was conducted on qualitative data. RESULTS: 1061 women completed the survey. Respondents were likely to accept maternal RSV vaccination (89.5 %, 95 % CI 87.5-91.3) or infant immunisation (81.4 %, 95 % CI 79.0-83.7). Multivariable analysis showed higher acceptability was associated with having a partner and possible association with ethnicity. No difference was observed by deprivation, or disability status on multivariable analysis. Participants most trusted midwives for information. CONCLUSION: Maternal and infant RSV immunisations were both highly acceptable, supporting the roll out of either programme. Ongoing monitoring will support evaluation of programme implementation and equity of access.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Broad J, Letley L, Adair G, et al. An England-wide survey on attitudes towards antenatal and infant immunisation against respiratory syncytial virus amongst pregnant and post-partum women. Vaccine. 2025. PMID: 40652687. doi:10.1016/j.vaccine.2025.127482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。